Abstract:Objective:To observe the effects of transurethral split of the prostate (TUSP) on the urodynamics, the sexual function and the quality of life of benign prostatic hyperplasia.Methods:Eighty patients with benign prostatic hyperplasia admitted to the Deqing People′s Hospital of Zhejiang Province from January 2017 to June 2019 were enrolled into the research objects prospectively. According to the random digits table method, they were divided into group A and group B, with 40 cases in each group. The group A was treated with TUSP, while the group B was treated with bipolar transurethral plasma kinetic prostatectomy (TUPKP). The operation time, intraoperative blood loss, bladder irrigation time, urinary catheter indwelling time, hospitalization time of the two groups were compared and surgical effects were evaluated. The changes of hemoglobin (Hb), serum sodium (Na), post-void residual volume (PVR), maximum urinary flow rate (Q max), international prostate symptom score (IPSS) and international index of erectile function score (IIEF-5), the quality of life index (QOL) of 2 groups before and after the operation were measured. Surgical complications were recorded. Results:The operation time, bladder irrigation time, urinary catheter indwelling time and hospital stay in group A were all shorter than that in group B: (15.63 ± 4.17) min vs. (58.79 ± 10.45) min, (6.26 ± 1.17) h vs. (45.51 ± 10.03) h, (3.07 ± 0.68) d vs. (5.67 ± 1.51) d, (3.63 ± 0.43) d vs. (6.08 ± 1.72) d, (18.32 ± 2.79) ml vs. (65.26 ± 20.64) ml, and there were statistical differences ( P<0.05); there were no statistical difference between 2 groups in surgical curative effect grade and Na 1 d after operation ( P>0.05); 1 day after operation, Hb in group A was higher than that in group B: (115.63 ± 9.78) g/L vs. (109.65 ± 8.36) g/L, and there was statistical difference ( P<0.05); PVR, Q max, IPSS, IIEF-5 and QOL 3 and 6 months after surgery were improved in 2 groups ( P<0.05), but the difference between 2 groups was not statistically significant ( P>0.05); the total complication rate in group A was lower than that in group B: 10.00% (4/40) vs. 27.50% (11/40), and there was statistical difference ( P<0.05). Conclusions:TUSP and TUPKP are equally effective in the treatment of benign prostatic hyperplasia, both of which can improve the symptoms of prostatic hyperplasia, improve the quality of life and improve sexual function. But TUSP has less intraoperative bleeding, shorter operation time, faster postoperative recovery, fewer complications, and higher safety.

Effect and Safety of Transrectal ~(137)Cs γ-rays in the Treatment of Benign Prostatic Hyperplasia

[Effect and Safety of Transrectal 137 CS Gamma-Rays in the Treatment of Benign Prostatic Hyperplasia].

The value of transurethral cylindrical dilatation of the prostate in the treatment of patients with benign prostatic hyperplasia

A comparative study of two means of simultaneous treatment for benign prostate hyperplasia and bladder stone

High-risk benign prostatic hyperplasia patients treated with transurethral resection of prostate

Six Novel Minimally Invasive Therapies for Benign Prostatic Hyperplasia

The Early New Clinical Experience of HIFU for Benigh Prostatic Hyperplasia

Efficacy of Transurethral Resection of the Microscope over the Same Period of Benign Prostatic Hyperplasia and Bladder Stones

Effect of dual-band semiconductor laser transurethral resection of prostate on efficacy, stress response and quality of life in patients with benign prostatic hyperplasia

Clinical effect of bipolar plasmakinetic transurethral enucleation in the treatment of benign prostatic hyperplasia

Ultrasound-guided transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a new minimally invasive interventional therapy

[Effect and safety of GreenLight HPS 120-W laser vaporization of the prostate for different benign prostatic hyperplasia populations]

Transurethral bipolar plasmakinetic prostatectomy for benign prostatic hyperplasia in high-risk and senior patients in China: a systematic review and meta-analysis

Transurethral Electrochemical Treatment of Benign Prostatic Hyperplasia

Clinical analysis of permanent transperineal ~(125)I seeds implantation for localized prostate cancer under transrectal ultrasound guidance(report of 10 cases)

Clinical Efficacy of TKRP Surgery and Its Effect on Serum PSA Level for Treating the Patients with Benign Prostatic Hyperplasia

One-year Effect of Ultrasound Guided Transurethral Balloon Dilation of Prostate for the Treatment of Benign Prostatic Hyperplasia

[Transperineal Ultrasonic Therapy for Chronic Prostatitis].

Study on the efficacy and safety of Transurethral enucleation and resection of the prostate in treatment of IV grade Benign prostatic hyperplasia

Prevention and treatment of rectal complications after ~(125)I brachytherapy for prostate cancer

Electrochemistry for the treatment of benign prostatic hyperplasia